The overall goal of this project is to learn more about the biosynthesis, pharmacology, mechanism of action and degradation of allergic mediators. Particular attention will be given to the 5-lipoxygenase products, leukotrienes, B, C, D and E, and 5-HETE because of their already demonstrated potency as spasmogenic agents or modulators of leukocyte function. Considerable emphasis will be given to the continuation of ongoing studies with the initial enzyme in leukotriene synthesis, the 5-lipoxygenase. The 5-lipoxygenases in RBL-1 cells, normal leukocytes and mast cells will be characterized in regard to their molecular structures, mechanism of activation, biosynthesis and degradation, subcellular distribution, immunochemical reactivity, susceptibility to pharmacologic inhibition, substrate specificity and mechanism of triggering in intact cells. Eventually we hope to determine whether there are abnormalities of this enzyme that contribute to human disease. Studies will also be directed toward an improved understanding of the mechanism of action of the leukotrienes both by defining the specific receptors through which they affect cellular function and by attempting to determine their biochemical mechanism of action. Similar studies are planned with the monohydroxyeicosatetraenoates. Other efforts will be directed toward improved methods for quantitation of the leukotrienes and their metabolites which may permit comparative studies of their production in allergic and non allergic individuals. Other active areas of research in our laboratory are concerned with IgE receptors and control of lymphocyte responsiveness through newly acquired cell surface proteins and soluble mediators such as T cell growth factor.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center (P50)
Project #
Application #
Study Section
Allergy and Immunology Research Committee (AIRC)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Flaskerud, J H; Nyamathi, A M (2000) Attaining gender and ethnic diversity in health intervention research: cultural responsiveness versus resource provision. ANS Adv Nurs Sci 22:15-Jan
Fisher Jr, E B; Strunk, R C; Sussman, L K et al. (1996) Acceptability and feasibility of a community approach to asthma management: the Neighborhood Asthma Coalition (NAC). J Asthma 33:367-83
Krishnan, B R; Jamry, I; Berg, D E et al. (1995) Construction of a genomic DNA 'feature map' by sequencing from nested deletions: application to the HLA class I region. Nucleic Acids Res 23:117-22
Krishnan, B R; Jamry, I; Chaplin, D D (1995) Feature mapping of the HLA class I region: localization of the POU5F1 and TCF19 genes. Genomics 30:53-8
Parker, C W; Huber, M G; Godt, S M (1995) Modulation of IL-4 production in murine spleen cells by prostaglandins. Cell Immunol 160:278-85
Nakayama, K; Nakayama, K; Negishi, I et al. (1994) Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci U S A 91:3700-4
Gasser, D L; Sternberg, N L; Pierce, J C et al. (1994) P1 and cosmid clones define the organization of 280 kb of the mouse H-2 complex containing the Cps-1 and Hsp70 loci. Immunogenetics 39:48-55
Telen, M J; Rao, N; Udani, M et al. (1994) Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 84:3205-11
Nygard, N R; Giacoletto, K S; Bono, C et al. (1994) Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells. J Immunol 152:1082-93
Nowicki, B; Hart, A; Coyne, K E et al. (1993) Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med 178:2115-21

Showing the most recent 10 out of 60 publications